Biotech headlines Monday's session. Moderna reported strong 5-year cancer vaccine data and expanded its CEPI partnership — yet the stock fell. That price-vs-news disconnect echoes the sentiment split flagged this week in AI health names. Fate Therapeutics is also in focus after presenting CAR T-cell data at ASCO today, with shorts holding 10.8% of free float and call buyers potentially ready to squeeze.
Earnings season rolls on. Ulta Beauty reports tonight. Dollar General faces its Q1 preview tomorrow, with analysts asking whether higher gas prices cushion the discount retailer. Hewlett Packard Enterprise (HPE) is also in the spotlight — traders are watching closely for commentary on AI server demand.
On the short side, Snowflake is grabbing attention. A historic stock run is reportedly forcing a short-covering scramble across the SaaS sector, dragging in names like and . remains the most shorted US stock at 130% of free float.
Analysts lifted targets across tech. Evercore raised CrowdStrike to $710. Wells Fargo pushed Seagate to $900 and Intel to $110.
SoftBank overtook Toyota to become Japan's largest company by market cap. AI-driven demand powered the milestone. It's a signal of how far the AI trade has shifted capital flows globally. Separately, FT reports global asset managers have captured just 0.1% of the Chinese market in five years — a reminder of structural limits in that growth story.
Wall Street bulls are shrugging off bubble fears, betting AI-linked stocks can push higher despite stretched valuations — a theme running across the short interest, options, and analyst data this week.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
